Literature DB >> 27000499

Efficient and Durable Vaccine against Intimin β of Diarrheagenic E. Coli Induced by Clay Nanoparticles.

Weiyu Chen1, Bing Zhang2, Timothy Mahony3, Wenyi Gu1, Barbara Rolfe1, Zhi Ping Xu1.   

Abstract

Improved strategies are urgently required to control infections with enterohemorrhagic Escherichia coli and enteropathogenic E. coli, two dominant zoonotic enteric pathogens responsible for a wide spectrum of illnesses as well as deaths of human being, with tremendous financial cost worldwide. The present study investigates the capacity of two clay nanoparticles (NPs) with opposite surface charges, namely synthetic layered double hydroxide (LDH) and hectorite (HEC) NPs as adjuvants to promote strong immune responses against the infections. Here both LDH and HEC NPs are showed to be able to carry an appreciable amount of Intimin β (1.1 and 4.4 mg per mg clay nanomaterials, respectively) and significantly facilitate antigen uptake by antigen-presenting cells. Remarkably, these clay NPs induce strong antibody and cell-mediated immune responses, which are much higher than that by the potent adjuvant, QuilA. Furthermore, these strong immune responses are well maintained for at least four months in the mouse model, during which there are no changes in histopathology of the animal organs. Collectively these data demonstrate the suitability of LDH and HEC NPs as useful adjuvants in new-generation vaccine formulations to control various infectious diseases.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  clay nanoparticles; hectorite; intimin β; layered double hydroxides; vaccine adjuvants

Mesh:

Substances:

Year:  2016        PMID: 27000499     DOI: 10.1002/smll.201503359

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  12 in total

Review 1.  2D Nanoclay for Biomedical Applications: Regenerative Medicine, Therapeutic Delivery, and Additive Manufacturing.

Authors:  Akhilesh K Gaharwar; Lauren M Cross; Charles W Peak; Karli Gold; James K Carrow; Anna Brokesh; Kanwar Abhay Singh
Journal:  Adv Mater       Date:  2019-04-03       Impact factor: 30.849

Review 2.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

3.  Efficient induction of comprehensive immune responses to control pathogenic E. coli by clay nano-adjuvant with the moderate size and surface charge.

Authors:  Weiyu Chen; Huali Zuo; Timothy J Mahony; Bing Zhang; Barbara Rolfe; Zhi Ping Xu
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

4.  Enhancing PD-1 Gene Silence in T Lymphocytes by Comparing the Delivery Performance of Two Inorganic Nanoparticle Platforms.

Authors:  Yanheng Wu; Wenyi Gu; Li Li; Chen Chen; Zhi Ping Xu
Journal:  Nanomaterials (Basel)       Date:  2019-01-28       Impact factor: 5.076

5.  Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7.

Authors:  Javier I Sanchez-Villamil; Daniel Tapia; Alfredo G Torres
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

Review 6.  Smart H2S-Triggered/Therapeutic System (SHTS)-Based Nanomedicine.

Authors:  Weiyu Chen; Dalong Ni; Zachary T Rosenkrans; Tianye Cao; Weibo Cai
Journal:  Adv Sci (Weinh)       Date:  2019-10-14       Impact factor: 16.806

7.  Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs.

Authors:  Peng Wu; Yunfeng Zhang; Xinyue Yin; Yanhua He; Qian Zhang; Chuangfu Chen
Journal:  BMC Vet Res       Date:  2020-12-04       Impact factor: 2.741

Review 8.  Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy.

Authors:  Ting Cai; Huina Liu; Shun Zhang; Jing Hu; Lingxiao Zhang
Journal:  J Nanobiotechnology       Date:  2021-11-25       Impact factor: 10.435

9.  Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice.

Authors:  Zahra Sadat Hosseini; Jafar Amani; Fahimeh Baghbani Arani; Shahram Nazarian; Mohammad Javad Motamedi; Fatemeh Shafighian
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29

10.  The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines.

Authors:  Shiyu Yan; Kewei Xu; Li Li; Wenyi Gu; Barbara E Rolfe; Zhi P Xu
Journal:  Front Pharmacol       Date:  2018-09-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.